Yorktown Management & Research Company’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Hold |
1,800
| – | – | 0.26% | 178 |
|
|
2025
Q1 | $271K | Hold |
1,800
| – | – | 0.29% | 166 |
|
|
2024
Q4 | $332K | Hold |
1,800
| – | – | 0.32% | 156 |
|
|
2024
Q3 | $355K | Hold |
1,800
| – | – | 0.36% | 137 |
|
|
2024
Q2 | $372K | Hold |
1,800
| – | – | 0.4% | 107 |
|
|
2024
Q1 | $488K | Hold |
1,800
| – | – | 0.46% | 69 |
|
|
2023
Q4 | $426K | Hold |
1,800
| – | – | 0.44% | 86 |
|
|
2023
Q3 | $353K | Hold |
1,800
| – | – | 0.4% | 103 |
|
|
2023
Q2 | $378K | Hold |
1,800
| – | – | 0.41% | 111 |
|
|
2023
Q1 | $363K | Hold |
1,800
| – | – | 0.39% | 101 |
|
|
2022
Q4 | $392K | Hold |
1,800
| – | – | 0.48% | 88 |
|
|
2022
Q3 | $354K | Hold |
1,800
| – | – | 0.46% | 80 |
|
|
2022
Q2 | $385K | Hold |
1,800
| – | – | 0.5% | 86 |
|
|
2022
Q1 | $511K | Hold |
1,800
| – | – | 0.43% | 94 |
|
|
2021
Q4 | $678K | Hold |
1,800
| – | – | 0.46% | 61 |
|
|
2021
Q3 | $743K | Hold |
1,800
| – | – | 0.56% | 37 |
|
|
2021
Q2 | $666K | Hold |
1,800
| – | – | 0.52% | 41 |
|
|
2021
Q1 | $522K | Hold |
1,800
| – | – | 0.43% | 68 |
|
|
2020
Q4 | $450K | Hold |
1,800
| – | – | 0.4% | 104 |
|
|
2020
Q3 | $408K | Sell |
1,800
-1,700
| -49% | -$385K | 0.38% | 99 |
|
|
2020
Q2 | $610K | Buy |
3,500
+1,700
| +94% | +$296K | 0.55% | 23 |
|
|
2020
Q1 | $227K | Buy |
+1,800
| New | +$227K | 0.23% | 191 |
|
|
2018
Q4 | – | Sell |
-3,000
| Closed | -$404K | – | 324 |
|
|
2018
Q3 | $404K | Hold |
3,000
| – | – | 0.12% | 182 |
|
|
2018
Q2 | $337K | Hold |
3,000
| – | – | 0.1% | 230 |
|
|
2018
Q1 | $320K | Buy |
+3,000
| New | +$320K | 0.09% | 239 |
|